• / Free eNewsletters & Magazine
  • / My Account
Home>Funds>Central Securities

Central Securities

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Husqvarna AB: Invitation – second quarter results presentation

    Husqvarna AB: Invitation – second quarter results presentation

  2. Alfa Laval: Invitation to Alfa Laval’s Second-Quarter Conference Call

    Alfa Laval: Invitation to Alfa Laval’s Second-Quarter Conference Call

  3. Orexo signs license agreement with Mundipharma, which obtains ex-US global rights to Zubsolv®

    Orexo signs license agreement with Mundipharma, which obtains ex-US global rights to Zubsolv®

  4. Increased Number of Shares and Votes in Castellum

    Increased Number of Shares and Votes in Castellum

  5. Eutelsat Communications: New Strategic Priorities and Financial Objectives

    Eutelsat Communications: New Strategic Priorities and Financial Objectives

  6. SCA: Invitation to SCA’s Q2 2016 Press Conference

    SCA: Invitation to SCA’s Q2 2016 Press Conference

  7. GlycoMimetics’ GMI-1271 Yields High Remission Rates and Favorable Tolerability in Phase 1 Portion of Phase 1/2 Clinical Trial for AML

    GlycoMimetics’ GMI-1271 Yields High Remission Rates and Favorable Tolerability in Phase 1 Portion of Phase 1/2 Clinical Trial for AML

  8. Central Securities Presents Rare Investment Opportunity

    Realizing a huge capital gain has put this closed-end fund's share price and discount in the spotlight.

  9. 2 Temptations That Trip Up CEF Investors

    Proper comparisons can help you avoid missteps.

  10. What Are Closed-End Funds?

    Closed-end funds aren?t very popular these days, especially when compared with their well-known cousins, open-end funds (which are more commonly known as mutual funds). However, closed-end funds have actually been around longer, and they have some benefits that make them worth a look--as well as ...

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.